Intelligence Β· Clinical Pipeline

LIGAND PHARMACEUTICALS Pipeline

All ClinicalTrials.gov programs at LIGAND PHARMACEUTICALS β€” phase, modality, and trial IDs.

Programs
3

Quick answer

LIGAND PHARMACEUTICALS has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Intravenous Carbamazepine (IV CBZ)

    LIGAND PHARMACEUTICALS INC

    Epilepsy

    phase 3 small molecule completed

    1 trial
  2. Targretin Gel 1%

    LIGAND PHARMACEUTICALS INC

    Alopecia Areata

    phase 3 small molecule completed

    1 trial
  3. lasofoxifene

    LIGAND PHARMACEUTICALS INC

    Osteoporosis

    phase 3 small molecule completed

    3 trials

Frequently asked questions

How many pipeline programs does LIGAND PHARMACEUTICALS have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs